International consensus statement on allergy and rhinology: rhinosinusitis 2021

RR Orlandi, TT Kingdom, TL Smith… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

[HTML][HTML] Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review

A Strzelak, A Ratajczak, A Adamiec… - International journal of …, 2018 - mdpi.com
Many studies have been undertaken to reveal how tobacco smoke skews immune
responses contributing to the development of chronic obstructive pulmonary disease …

Epidemiology of chronic rhinosinusitis: prevalence and risk factors

AR Sedaghat, EC Kuan, GK Scadding - The Journal of Allergy and Clinical …, 2022 - Elsevier
Knowledge of chronic rhinosinusitis (CRS) epidemiology may directly impact patient care:
aiding patient identification and establishing accurate diagnosis as well as informing …

International consensus statement on allergy and rhinology: rhinosinusitis

RR Orlandi, TT Kingdom, PH Hwang… - International forum of …, 2016 - Wiley Online Library
Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham,
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …

European position paper on rhinosinusitis and nasal polyps 2012

WJ Fokkens, VI Lund, J Mullol, C Bachert, I Alobid… - Rhinology, 2012 - biblio.ugent.be
The methodology for EPOS2012 has been the same as for the other two productions.
Leaders in the field were invited to critically appraise the literature and write a report on a …

[HTML][HTML] ICON: chronic rhinosinusitis

C Bachert, R Pawankar, L Zhang, C Bunnag… - World Allergy …, 2014 - Springer
Chronic rhinosinusitis (CRS) is a public health problem that has a significant socio-
economic impact. Moreover, the complexity of this disease due to its heterogeneous nature …

The preclinical pharmacology of roflumilast–a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease

A Hatzelmann, EJ Morcillo, G Lungarella… - Pulmonary …, 2010 - Elsevier
After more than two decades of research into phosphodiesterase 4 (PDE4) inhibitors,
roflumilast (3-cyclopropylmethoxy-4-difluoromethoxy-N-[3, 5-di-chloropyrid-4-yl]-benzamide) …

[HTML][HTML] Indoor PM2. 5, tobacco smoking and chronic lung diseases: a narrative review

Y Ni, G Shi, J Qu - Environmental research, 2020 - Elsevier
The lung is one of the most important organs exposed to environmental agents. People
spend approximately 90% of their time indoors, and risks to health may thus be greater from …

Epidemiology and differential diagnosis of nasal polyps

MR Chaaban, EM Walsh… - American journal of …, 2013 - journals.sagepub.com
Background Chronic rhinosinusitis (CRS) is one of the most common chronic medical
conditions, with a significant impact on patient quality of life. CRS is broadly classified into …

Impact of tobacco smoke on chronic rhinosinusitis: a review of the literature

DD Reh, TS Higgins, TL Smith - International forum of allergy & …, 2012 - Wiley Online Library
Background: Environmental factors such as inhaled pollutants like cigarette smoke may play
a significant role in diseases of the upper airway including chronic rhinosinusitis (CRS). The …